|
End-of-day quote
Dhaka S.E.
12/11/2026
|
5-day change | 1st Jan Change | ||
| 725.90 BDT | -1.16% |
|
+0.61% | +2.53% |
| Market Cap | 1.82B 14.52M 13.16M 12.17M 10.98M 20.7M 1.37B 21.43M 146M 57.99M 732M 54.5M 53.35M 2.32B | P/E 2024 |
189x | P/E 2025 | 369x |
|---|---|---|---|---|---|
| Enterprise Value | 2.32B 18.57M 16.83M 15.57M 14.05M 26.47M 1.75B 27.4M 187M 74.16M 935M 69.7M 68.22M 2.97B | EV / Sales 2024 |
10.4x | EV / Sales 2025 | 10.7x |
| Free-Float |
22.75% | Yield 2024 |
0.13% | Yield 2025 | 0.12% |
| 1 day | -1.16% | ||
| 1 week | +0.61% | ||
| Current month | -0.66% | ||
| 1 month | -1.21% | ||
| 3 months | -9.58% | ||
| 6 months | -4.02% | ||
| Current year | +2.53% |
| 1 week | 718 |  | 738 |
| 1 month | 700.5 | | 756.6 |
| Current year | 689 | | 847 |
| 1 year | 681 | | 847 |
| 3 years | 650 | | 1,002.7 |
| 5 years | 375.3 | | 1,302.3 |
| 10 years | 353 | | 1,302.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
Nurjehan Hudda
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.16% | +0.61% | -1.83% | -14.67% | 13.94M | |
| +1.26% | +6.61% | +41.12% | +135.59% | 1,286B | |
| +0.79% | +3.45% | +46.35% | +93.56% | 688B | |
| +0.20% | +1.28% | +27.01% | +112.80% | 521B | |
| -0.44% | +3.69% | +39.60% | +69.51% | 386B | |
| +0.55% | +0.70% | +59.00% | +44.20% | 364B | |
| -0.12% | +0.74% | +26.78% | +58.43% | 302B | |
| +0.37% | +0.37% | +3.62% | +36.44% | 287B | |
| -0.30% | +1.14% | +38.59% | +74.61% | 252B | |
| +0.08% | +0.71% | +34.25% | +124.32% | 208B | |
| Average | +0.12% | +1.97% | +31.45% | +73.48% | 429B | |
| Weighted average by Cap. | +0.54% | +3.26% | +37.63% | +96.23% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 219M 1.75M 1.59M 1.47M 1.33M 2.5M 165M 2.59M 17.66M 7M 88.36M 6.58M 6.44M 280M | 231M 1.84M 1.67M 1.55M 1.39M 2.63M 174M 2.72M 18.57M 7.36M 92.89M 6.92M 6.77M 295M |
| Net income | 9.68M 77.46K 70.2K 64.93K 58.58K 110K 7.3M 114K 780K 309K 3.9M 291K 285K 12.38M | 5.31M 42.47K 38.49K 35.6K 32.12K 60.53K 4M 62.66K 428K 170K 2.14M 159K 156K 6.79M |
| Net Debt | 445M 3.56M 3.22M 2.98M 2.69M 5.07M 335M 5.25M 35.82M 14.2M 179M 13.35M 13.07M 569M | 506M 4.05M 3.67M 3.39M 3.06M 5.77M 382M 5.98M 40.78M 16.17M 204M 15.2M 14.88M 648M |
Employees
474
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/11/26 | BDT 725.90 | -1.16% | 58 |
| 11/11/26 | BDT 734.40 | +1.83% | 28 |
| 10/11/26 | BDT 721.20 | -2.04% | 458 |
| 09/11/26 | BDT 736.20 | +2.42% | 1,076 |
| 08/11/26 | BDT 718.80 | -0.37% | 155 |
- Stock Market
- Stocks
- AMBEEPHA Stock
Select your edition
All financial news and data tailored to specific country editions
